It has been found that CSC/TIC secretes more cytokines such as TGF-β (transforming growth factor beta; in breast cancer and glioblastoma) or IL-4 (in colon cancer) than cancer cells reducing the immune response and escalating drug resistance [94, 95]. This evidence concerns the gene TGFB1 and breast carcinoma.